By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Titan Pharmaceuticals, Inc. 

400 Oyster Point Boulevard, Suite 505

South San Francisco  California  94080-1921  U.S.A.
Phone: 650-244-4990 Fax: 650-244-4956



Company News
Titan Pharmaceuticals (TTP) Announces Pricing Of Public Offering 10/3/2014 10:00:44 AM
Titan Pharmaceuticals (TTP) Announces Enrollment Reaches Halfway Mark In Phase 3 Study Of Probuphine For Opioid Dependence 9/23/2014 11:36:38 AM
Titan Pharmaceuticals (TTP) To Present At Rodman & Renshaw 16th Annual Global Investment Conference 9/4/2014 1:02:30 PM
Titan Pharmaceuticals (TTP) Schedules Conference Call To Review Second Quarter 2014 Financial Results 8/8/2014 10:08:03 AM
Highline Research Advisors Initiates On Titan Pharmaceuticals (TTP) With A Buy Rating 7/7/2014 11:04:25 AM
Titan Pharmaceuticals (TTP) Receives Notice Of Allowance For Patent Of Implantable Polymeric Device For Sustained Release Of Dopamine Agonists 6/10/2014 10:18:59 AM
Titan Pharmaceuticals (TTP) Announces First Quarter 2014 Financial Results 5/15/2014 10:13:59 AM
Titan Pharmaceuticals (TTP) Schedules Conference Call To Review First Quarter 2014 Financial Results 5/9/2014 8:41:23 AM
Titan Pharmaceuticals (TTP) Provides Overview Of Upcoming Clinical Study Of Probuphine Following Clear Guidance From The FDA 4/30/2014 3:44:36 PM
Titan Pharmaceuticals (TTP) Announces Fourth Quarter And Year End 2013 Financial Results 4/1/2014 9:33:09 AM